Alkem Imperia Online Quiz - June'2018

20 Questions | Total Attempts: 177

SettingsSettingsSettings
Alkem Imperia Online Quiz - June

Alkem Imperia


Questions and Answers
  • 1. 
    Dose of Dabiclot in patients with creatinine clearance 15-30ml/min will be:
    • A. 

      150mg BID

    • B. 

      110mg BID

    • C. 

      75mg BID

    • D. 

      Not recommended

  • 2. 
    Why will a dr prefer Dabiclot over other brands of Dabigatran
    • A. 

      Innovative manufacturing process to overcome technical challenges

    • B. 

      HPMC capsule shell

    • C. 

      Bioequivalence study compared with US Innovator

    • D. 

      All of the above

  • 3. 
    Dabiclot 110mg reduces risk of intracranial bleeding over Warfarin by what percent:
    • A. 

      69%

    • B. 

      65%

    • C. 

      60%

    • D. 

      55%

  • 4. 
    RELYABLE trial was an extension of RELY trail for how many years:
    • A. 

      4 years

    • B. 

      6 years

    • C. 

      2.3 years

    • D. 

      1 year

  • 5. 
    Dabiclot reduces the risk of first stroke or systemic embolism over warfarin by:
    • A. 

      20%

    • B. 

      25%

    • C. 

      30%

    • D. 

      35%

  • 6. 
    What is HPMC?
    • A. 

      Hydroxy Pentyl Mono Cellulose

    • B. 

      Hydroxy Propyl Methyl Cellulose

    • C. 

      Hydro Propane Methane Cellulose

    • D. 

      None of the above

  • 7. 
    What is MUPS technology?
    • A. 

      Multiple Particulate technology

    • B. 

      Multi Unit Particulate System technology

    • C. 

      Multi Para System technology

    • D. 

      None of the above

  • 8. 
    What is the quantity of JAPI reprints received per ME?
    • A. 

      20

    • B. 

      40

    • C. 

      30

    • D. 

      60

  • 9. 
    What is the quantity of Business Desk Lamp received per ME?
    • A. 

      20

    • B. 

      40

    • C. 

      30

    • D. 

      10

  • 10. 
    Clot Case Series Issue 6 talks about which of the following topics:
    • A. 

      Use of Dabigatran in patient not responding to Warfarin

    • B. 

      Use of Dabigatran in a non anti coagulated patient determined on basis of CHADSVASc Score

    • C. 

      Use of Dabigatran in patient with AF on antiplatelet therapy

    • D. 

      None of the above

  • 11. 
    The special input (Business desk Lamp) will be given on priority to which set of drs:
    • A. 

      RM/DSM adopted drs

    • B. 

      20 drs selected for effort driven conversion for Dabiclot

    • C. 

      10 drs selected for Ezuric/Muzika

    • D. 

      Any dr out of 60

  • 12. 
    Dabiclot brand reminder input for the month of May was:
    • A. 

      Dabiclot paper weight

    • B. 

      Dabiclot Chit pad

    • C. 

      Dabiclot Rx pad

    • D. 

      None of the above

  • 13. 
    Muzika is indicated in which class of patients:
    • A. 

      NYHA Class I

    • B. 

      NYHA Class II

    • C. 

      NYHA Class III

    • D. 

      NYHA Class III – IV

  • 14. 
    Ezuric is indicated in which class of patients:
    • A. 

      NYHA Class I

    • B. 

      NYHA Class II

    • C. 

      NYHA Class III

    • D. 

      NYHA Class II – IV

  • 15. 
    Ezuric/Muzika is being promoted to how many doctors?
    • A. 

      5

    • B. 

      10

    • C. 

      15

    • D. 

      20

  • 16. 
    Chemist availability for Ezuric/Muzika is to be done at how many retailers?
    • A. 

      10

    • B. 

      20

    • C. 

      30

    • D. 

      40

  • 17. 
    Which competitor brand(s) will you focus on for conversion to Ezuric?­­­­
    • A. 

      Isodac

    • B. 

      Eptus

    • C. 

      Planep

    • D. 

      Both b & c are true

  • 18. 
    Which competitor brand will you focus on for conversion to Muzika?
    • A. 

      Isolazine

    • B. 

      Isoflav

    • C. 

      Isodac

    • D. 

      Isoniazid

  • 19. 
    In case of the Drs being targeted for Ezuric and Muzika, which brand will be promoted first?
    • A. 

      Dabiclot

    • B. 

      Ezuric

    • C. 

      Muzika

    • D. 

      Any of the above

  • 20. 
    What are the competitors of Dabiclot?
    • A. 

      Pradaxa

    • B. 

      Dabistar

    • C. 

      Dabigat

    • D. 

      All options are true

Back to Top Back to top